Physician profile
Robert Cohen
NPI 1053381574
$594.68
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $356 · 2020: $44.79 · 2021: $170 · 2024: $24.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $24.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $24.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $300.00 | 2019-2021 | |
| Merz North America, INC. | $25.28 | 2020 | |
| Catalyst Pharmaceuticals, INC. | $24.68 | 2019 | |
| Abbvie INC. | $24.00 | 2024 | |
| Acadia Pharmaceuticals INC | $23.23 | 2019 | |
| Akcea Therapeutics, INC. | $21.11 | 2019 | |
| Sunovion Pharmaceuticals INC. | $20.85 | 2019 | |
| Ucb, INC. | $20.41 | 2019 | |
| Kyowa Kirin, INC. | $20.14 | 2021 | |
| Genentech USA, INC. | $19.51 | 2020 | |
| Grifols USA, LLC | $19.09 | 2019 | |
| Alexion Pharmaceuticals, INC. | $18.37 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.87 | 2019 | |
| Mallinckrodt Enterprises LLC | $16.61 | 2019 | |
| Genzyme Corporation | $13.07 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $11.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.